Moderna Merck Cancer Trial Seeks Better Melanoma Treatment Results
A clinical trial has been launched by Moderna and Merck to test the effectiveness of a combination treatment for cancer.
The trial will focus on patients with advanced melanoma, the most aggressive form of skin cancer.
According to Bill Sikes, AP, 'The goal is to see if this combination can provide better results than existing treatments.'